Minimally Invasive and Novel Therapeutics

September 13-15, 2023

Next annual meeting: September 13th-15th 2023

About MINT

Current treatment strategies for patients with complex foregut disorders continue to evolve largely as a result of growing technological advances in surgery and endoscopy.

The goal of the Minimally Invasive and Novel therapeutics (MINT) course is to inform practicing physicians and providers on how best to incorporate these technologies into their practice.

Using a video-based format, our goal is technique transfer from world-renowned faculty to your community, hospital, endoscopy suite, and operating room. MINT offers an ideal mix of the traditional standard-of-care principles with a balanced and unbiased view of new, cutting-edge information on topics including:

• Heartburn and reflux
• Antireflux surgery and redo fundoplication
• achalasia and esophageal motility disorders
• oropharyngeal and esophageal strictures
• POEM and POP
• Barrett’s esophagus (including The role of antireflux surgery in patients with Barretts, Prognostic factors, “Stubborn BE. What do I do now- burn, freeze, or give up?) and much more

This year we are excited to offer optional hands on sessions in:
• Endoluminal therapies
• Robotic Surgery
• Pancreatitis management

New for 2023:
• HERNIA and PANCREAS track on Friday 9/15/23

This is a Harvard Medical School-accredited course hosted in partnership with the Swallowing, Heartburn, Esophageal Disease (SHED) Program at Massachusetts General Hospital and the Heartburn and Reflux Program at Newton-Wellesley Hospital.